... [email protected]. Abstract Heart transplantation (HTx) is a definitive treatment for selected patients with advanced heart failure. However, primary graft dysfunction (PGD), a severe early complication, is a major cause of post-HTx morbidity and mortality. This paper explores the pathophysiology...

... in advanced heart failure and heart transplantation at the Hospital Clinic in Barcelona, Spain. He has special interest in LVADs and acute heart failure. Supplementary material is available at European Heart Journal – Case Reports online. Consent: The authors confirm that written consent...

.... Although it was necessary to deactivate one of the both leads due to thoracic pain, LVEF and HF symptoms significantly improved. Further research is needed to elaborate on the potential role of CCM therapy in genetic cardiomyopathies. Cardiac contractility modulation Advanced heart failure Genetic...

... through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected]. Abstract Aims In patients with advanced heart failure requiring dobutamine infusion, it is usually recommended to initiate beta-blockers after...

... [email protected] Abstract Patients with advanced heart failure, due to the instability of their clinical conditions, need close surveillance to avoid dangerous exacerbations or sudden events. Digital technology can be of great help in this contest, thanks to remote monitoring, made possible with the use...

... to thiocyanate toxicity. Despite aggressive calcium supplementation, the only way to reduce the arrhythmic burden was SNP down titration. Advanced heart failure Pharmacology Sodium nitroprusside Arrhythmias Case report Learning points To recognize the potential drawback of prolonged infusion of sodium...

... of the Oxford University Press, Standard Journals Publication Model ( https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights ) Abstract The evaluation of exercise capacity and cardiac output (Q_C) is fundamental in the management of patients with advanced heart failure (AdHF...

... as a bridge measure for cardiac transplantation. Case report Advanced heart failure Mitral regurgitation Tricuspid regurgitation Heart transplant HIV Learning points The mitral and tricuspid repair in advanced heart failure is an adequate strategy option as a bridge therapy until a heart becomes...

... (Frank-Starling adaptation). Stage C: symptoms and signs of heart failure, associated with reduced ejection fraction, increased end-diastolic volume, and filling pressure, yet stroke volume is only mildly reduced or preserved. Stage D: advanced heart failure, symptoms and signs of heart failure...

... in affected tissue. Outcomes in adult MCM patients who receive an LVAD are unknown and warrant further investigation. Mitochondrial cardiomyopathy Mitochondrial DNA disease Advanced heart failure Mechanical circulatory support device Case report Learning points Mitochondrial cardiomyopathy (MCM...

... is a challenging issue of progressive heart failure, especially in patients with adult congenital heart disease. Cell-free and concentrated ascites reinfusion therapy can improve refractory cardiac ascites in patients with advanced heart failure. Cardiac ascites, one of the classical right-sided heart failure...

... be fatal, and appropriate nutritional and medical interventions in patients with PA-related cardiomyopathy could result in myocardial recovery. Osamu Seguchi is a board-certified cardiologist and works for advanced heart failure therapies including mechanical circulatory support and heart transplantation...

... failure is a complex clinical syndrome associated with a high mortality and morbidity rate. Despite the extensive pharmacological armamentarium, a non-negligible percentage of patients develop advanced heart failure and require further therapies. In these circumstances, heart transplantation remains...

... and preventing HF through self-care behavioural changes, even in patients with advanced HF and severely reduced ejection fraction. Advanced heart failure (HF) is characterized by progressive symptoms, worsening cardiac function, and repeated hospitalization despite guideline-directed treatment. ¹...

... heart failure natriuretic peptides ejection fraction diagnosis pharmacotherapy neuro-hormonal antagonists cardiac resynchronization therapy mechanical circulatory support transplantation arrhythmias comorbidities hospitalization multidisciplinary management advanced heart failure acute...

... paper, released by the Italian Association of Hospital Cardiologists, reviews the available data derived from clinical studies. It also provides practical recommendations for the optimal use of IABP in the treatment of cardiogenic shock and advanced acute heart failure. Advanced heart failure...

...-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected] Abstract Background  The safety and efficacy of MitraClip for advanced heart failure (HF) patients who are inotrope-dependent...

... is 4.06 (95% CI 1.67–9.84, P < 0.001) and 7.25 (95% CI 2.7–19.5, P < 0.001), respectively. Conclusions Physical activity level evaluated by the PASE score is inversely related to mortality in elderly patients with advanced heart failure confirming the reduction of mortality...

... chronic heart failure. In the present review, we will focus on the utility of this agent in the wider context of i.v. inotropic and inodilating therapies for AHF and related pathologies. Acute heart failure Advanced heart failure Inotropes Inodilators Levosimendan Cardiogenic shock Right ventricular...

... in the European Society of Cardiology position statement on advanced heart failure (AdHF). ⁶ Advanced heart failure secondary to adult congenital heart disease (ACHD) represents a small subgroup posing unique challenges in terms of the specifics of its management. At present, Levosimendan remains under...